Over the last few years, the number of recombinant pharmaceutical products that have entered the regulatory fray to gain approval for marketing has grown rapidly, and is now in the hundreds. As ...
Master of Biotechnology program (MBP) student Anita Huang looks back on her six-month internship at UCB in the United Kingdom and what she learned from the experience. In 2019, two students in ...
As biopharma’s biologics portfolio continues to grow, its increasing complexity presents a number of challenges for biomanufacturers, according to Sanchayita Ghose, PhD, executive director, Downstream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results